Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121674) titled 'Effectiveness and Safety of IL-1 Inhibitors in Patients with Gout and Chronic Kidney Disease: A Prospective Multicenter Randomized Controlled Trial' on April 1.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: SHANGHAI TENTH PEOPLES HOSPITAL
Condition:
Gout combined with chronic kidney disease
Intervention:
IL-1 Inhibitor Anti-inflammatory + Conventional Urate-Lowering Therapy Group:IL-1 Inhibitor Anti-inflammatory + Febuxostat 40 mg qd Urate-Lowering Therapy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-01
Target Sample Size: IL-1 Inhibitor...